Avience Biomedicals IPO
The Avience Biomedicals IPO is an upcoming SME public issue on the NSE EMERGE platform, offering equity shares through a book-building process. The company operates in the healthcare sector and specializes in manufacturing in-vitro diagnostic (IVD) products and medical devices used for disease detection and laboratory testing. Incorporated recently, the company has shown notable financial growth, with revenue of around ₹45 crore and a profit after tax of approximately ₹7 crore on an annualized basis. The IPO primarily consists of a fresh issue of equity shares, and the proceeds are intended for setting up a new manufacturing facility in the Yamuna Expressway Industrial Development Authority (YEIDA) region, along with funding working capital and general corporate purposes. Backed by experienced promoters and operating in a growing diagnostics industry, the Avience Biomedicals IPO presents an opportunity for investors to participate in the expanding healthcare and biotech segment, although final pricing and subscription details are yet to be announced.
